The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McAllister, F.
Right arrow Articles by Kolls, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McAllister, F.
Right arrow Articles by Kolls, J. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Pneumocystis Infections
The Journal of Immunology, 2006, 177: 1846-1854.
Copyright © 2006 by The American Association of Immunologists

CXCR3 and IFN Protein-10 in Pneumocystis Pneumonia

Florencia McAllister1,*, Sanbao Ruan1,{dagger}, Chad Steele*, Mingquan Zheng*, Laura McKinley*, Lauren Ulrich*, Luis Marrero{dagger}, Judd E. Shellito{dagger} and Jay K. Kolls2,*

* Children’s Hospital of Pittsburgh, University of Pittsburgh, Department of Pediatrics, Pittsburgh, PA 15213; and {dagger} Louisiana State University Health Sciences Center Gene Therapy Program, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA 70112

We have previously shown that Tc1 CD8+ T cells have in vitro and in vivo effector activity against Pneumocystis (PC) infection in mice. Because these cells have preferential expression of CXCR3, we investigated whether CXCR3 was required for host defense activity against PC. Mice deficient in CXCR3 but CD4+ T cell intact, showed an initial delay but were able to clear the infectious challenge, indicating that CXCR3 signaling is not essential for clearance of PC. CD4-depleted mice had lower levels of monokine induced by IFN-{gamma}, IFN protein-10 (IP-10), and IFN-inducible T cell {alpha}-chemoattractant at day 7 of infection and are permissive to PC infection. Overexpression of IP-10 in the lungs by adenoviral gene transfer did not accelerate clearance of infection in control mice but accelerated clearance by day 28 in mice depleted of CD4+ T cells. This effect was associated with increased recruitment of CD8+ T to the lungs with higher CXCR3+ expression levels and enhanced IFN-{gamma} secretion upon in vitro activation compared with control mice. These results indicate that the CXCR3 chemokines are part of the host defense response to PC, and that IP-10 can direct Tc1 CD8+ T cell recruitment to the lungs and contribute to host defense against PC even in the absence of CD4+ T cells.




This article has been cited by other articles:


Home page
BloodHome page
J. Barbi, H. E. Cummings, B. Lu, S. Oghumu, T. Ruckle, C. Rommel, W. Lafuse, C. C. Whitacre, and A. R. Satoskar
PI3Kgamma (PI3K{gamma}) is essential for efficient induction of CXCR3 on activated T cells
Blood, October 15, 2008; 112(8): 3048 - 3051.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. Hernandez-Novoa, L. Bishop, C. Logun, P. J. Munson, E. Elnekave, Z. G. Rangel, J. Barb, R. L. Danner, and J. A. Kovacs
Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice
J. Leukoc. Biol., August 1, 2008; 84(2): 420 - 430.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Ruan, L. McKinley, M. Zheng, X. Rudner, A. D'Souza, J. K. Kolls, and J. E. Shellito
Interleukin-12 and Host Defense against Murine Pneumocystis Pneumonia
Infect. Immun., May 1, 2008; 76(5): 2130 - 2137.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.